2021年世界肺癌大会(WCLC)将于9月8日至14日以全球虚拟网络会议的形式隆重召开,作为世界上最大的肺癌和其他胸部恶性肿瘤会议,WCLC吸引着全球专家学者的目光,最新前沿进展令人目接不暇。WCLC日程目前已经公布,在“Oral Session”,多位中国学者将汇报最新研究成果,同时如往年一样,本次大会同样设立了中国专场。【肿瘤资讯】带您抢先一览!
“Oral Session”的中国好声音
专场:OA02——Contemporary Approaches to Supportive Care
报告标题:OA02.01 - Assessment of Patient-Reported Outcomes in Lung cancer Patients Treated with Thoracic Radiation
演讲者:Li Yang
专场:OA06——Prognosis and Staging
报告标题:OA06.01 - Validation of the 8th Ed TNM: Invasive Size for Pathologic T Descriptor in Stage Ⅰ~ⅡA Resected Nonmucinous Adenocarcinomas
演讲者:Yan Li
专场:OA07——What's On The Horizon for SCLC?
报告标题:OA07.02 - Phenotypic Transition Contributes to Small Cell Lung Cancer Metastasis Through SWI/SNF Complex-Induced TAZ Silencing
演讲者:YUJUAN JIN
专场:OA08 - Moving Beyond New Drugs: What Else Matters?
报告标题:OA08.03 - The 5-year Survival Rate of Postoperative Non-small Cell Lung Cancer Patients with Two Different Follow-up Patterns
演讲者:Daqiang Sun
专场:OA12 - Understanding and Augmenting Responses to Immunotherapy for Thoracic Malignancies
报告标题:OA12.03 - Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC
演讲者:Shuai Li
专场:OA14 - Global Disparities in Lung Cancer Care
报告标题:OA14.03 - Discussant
演讲者:吴楠教授,北京大学肿瘤医院
专场:OA16 - Clinical Impact of Liquid Biopsy for Patients with NSCLC
报告标题:OA16.03 - Matched Targeted Therapy by cfDNA of CSF Beyond Leptomeningeal Metastases Progression Upon Osimertinib in EGFR-Mutated NSCLC Patients
演讲者:郑媚美博士,广东省肺癌研究所,广东省人民医院
通讯作者:吴一龙教授,广东省肺癌研究所,广东省人民医院
专场:OA16 - Clinical Impact of Liquid Biopsy for Patients with NSCLC
报告标题:OA16.04 - A Combined Model of Clinical, Imaging and DNA Methylation Biomarkers to Improve the Classification of Pulmonary Nodules
演讲者:何建行教授,广东医科大学附属第一医院
“中国专场”日程
“Joint IASLC - CAALC - CSCO Workshop”(中国专场)也将于2021年9月11日22:15 - 23:45(美国山地时间;中国时间为9月12日12:15至13:45),详细日程如下:
更多详情请至官网查看:https://library.iaslc.org/conference-program?product_id=24
本文根据官方日程仅统计“Oral Session”中国专家报告内容,其他session内容将陆续更新,如有遗漏或补充请联系肿瘤资讯-小编,微信号:oncologynews。
排版编辑:Zack